Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DarioHealth Corp.DRIO · Entity 7024 | Director | February 24, 2025 | February 25, 2025 |
| Quorum Health CorpQHC · Entity 149783 | Director | November 26, 2019 | December 05, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DarioHealth Corp.
Report date February 24, 2025 · Filed February 25, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 111,574 |
Reported balance
After 2025-02-24 transaction · row 1
1 source rowRow 1 · 2025-02-24 · Grant · Acquired 30,000 · Balance 111,574 |
Quorum Health Corp
Report date November 26, 2019 · Filed December 05, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock UnitsSEC Table II · derivative / convertible security | Direct | 71,949.105 |
Reported balance
After 2019-11-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-11-26 · Grant · Acquired 28,295.616 · Balance 71,949.105 F1: Stock units are convertible into common stock on a 1-for-1 basis. F2: Represents 28,295.616 units accrued under the Quorum Health Corporation Amended and Restated Director's Fees Deferral Plan (the "Plan") in lieu of director cash compensation for the quarter ending December 31, 2019. F3: Payment of amounts credited to the reporting person's stock unit account will be made upon a payment commencement event, as defined in the Plan, in accordance with the payment method elected by the reporting person, either in lump sum or in a number of annual installments, not to exceed 15 installments. |
Filing footnotes · ownership attribution and instrument terms
F1: Stock units are convertible into common stock on a 1-for-1 basis.
F2: Represents 28,295.616 units accrued under the Quorum Health Corporation Amended and Restated Director's Fees Deferral Plan (the "Plan") in lieu of director cash compensation for the quarter ending December 31, 2019.
F3: Payment of amounts credited to the reporting person's stock unit account will be made upon a payment commencement event, as defined in the Plan, in accordance with the payment method elected by the reporting person, either in lump sum or in a number of annual installments, not to exceed 15 installments.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2025 Filed Feb 25, 2025 16:02 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-016923 · tm257590-1_4seq1.xml · nonDerivative · entry 1 KAPLAN JON H. · CIK 0001751699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,574 Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 16:21 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-032412 · tm248350-6_4seq1.xml · nonDerivative · entry 1 KAPLAN JON H. · CIK 0001751699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 F1 · date: The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in two instalments on the last day of each successive annual anniversary over a two year period. Read SEC document |
| May 04, 2023 Filed May 8, 2023 16:12 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseSeries B-2 Preferred Stock · Derivative | 30 | $1,000.00 Strike: $3.37 | $30,000.00 |
DisclosureSEC source: 0001104659-23-057158 · tm2315002-2_4seq1.xml · derivative · entry 1 KAPLAN JON H. · CIK 0001751699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30 Underlying: Common Stock · Not disclosed shares Expires 2026-05-04 F1 · derivative.expiration_date: The Series B Preferred Stock will automatically convert into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date. F2 · derivative.underlying_shares: The Series B Preferred Stock initially converts into shares of common stock at a conversion price of $3.37. In addition, the holders of Series B Preferred Stock will also be entitled dividends payable as follows: (i) a number of shares of Common Stock equal to five percent (5.0%) of the number of shares of Common Stock issuable upon conversion of the Series B Preferred Stock then held by such holder for each full quarter anniversary of holding for a total of four (4) quarters from the closing date, and (ii) a number of shares of common stock equal to ten percent (10%) of the number of shares of common stock issuable upon conversion of the Series B Preferred Stock then held by such holder on the fifth full quarter from the closing date. Read SEC document |
| November 26, 2019 Filed Dec 5, 2019 20:30 UTC | Quorum Health Corp QHC · Entity 149783 | GrantStock Units · Derivative | 28,295.616 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-018813 · ownership.xml · derivative · entry 1 KAPLAN JON H. · CIK 0001751699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,949.105 Underlying: Common Stock · 28,295.616 shares Expires not disclosed F1 · derivative.exercise_price: Stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Represents 28,295.616 units accrued under the Quorum Health Corporation Amended and Restated Director's Fees Deferral Plan (the "Plan") in lieu of director cash compensation for the quarter ending December 31, 2019. F3 · derivative.exercise_date: Payment of amounts credited to the reporting person's stock unit account will be made upon a payment commencement event, as defined in the Plan, in accordance with the payment method elected by the reporting person, either in lump sum or in a number of annual installments, not to exceed 15 installments. F3 · derivative.expiration_date: Payment of amounts credited to the reporting person's stock unit account will be made upon a payment commencement event, as defined in the Plan, in accordance with the payment method elected by the reporting person, either in lump sum or in a number of annual installments, not to exceed 15 installments. Read SEC document |
| August 29, 2019 Filed Sep 3, 2019 16:36 UTC | Quorum Health Corp QHC · Entity 149783 | GrantStock Units · Derivative | 23,684.211 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-013624 · ownership.xml · derivative · entry 1 KAPLAN JON H. · CIK 0001751699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,653.489 Underlying: Common Stock · 23,684.211 shares Expires not disclosed F1 · derivative.exercise_price: Stock units are convertible into common stock on a 1-for-1 basis. F2 · shares: Represents 23,684.211 units accrued under the Quorum Health Corporation Amended and Restated Director's Fees Deferral Plan (the "Plan") in lieu of director cash compensation for the quarter ending September 30, 2019. F3 · derivative.exercise_date: Payment of amounts credited to the reporting person's stock unit account will be made upon a payment commencement event, as defined in the Plan, in accordance with the payment method elected by the reporting person, either in lump sum or in a number of annual installments, not to exceed 15 installments. F3 · derivative.expiration_date: Payment of amounts credited to the reporting person's stock unit account will be made upon a payment commencement event, as defined in the Plan, in accordance with the payment method elected by the reporting person, either in lump sum or in a number of annual installments, not to exceed 15 installments. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 21:21 UTC | Quorum Health Corp QHC · Entity 149783 | GrantCommon stock, par value $0.0001 per share | 43,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-008607 · ownership.xml · nonDerivative · entry 1 KAPLAN JON H. · CIK 0001751699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,108 F1 · shares: On May 31, 2019, the reporting person received a grant of 43,478 shares of restricted common stock pursuant to the Quorum Health Corporation Amended and Restated 2016 Stock Award Plan. 100% of the number of shares of restricted stock issued shall vest, and the restrictions with respect to such restricted stock shall lapse, on February 14, 2020. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:21 UTC | Quorum Health Corp QHC · Entity 149783 | GrantStock Units · Derivative | 11,904.762 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-008607 · ownership.xml · derivative · entry 3 KAPLAN JON H. · CIK 0001751699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,969.278 Underlying: Common Stock · 11,904.762 shares Expires not disclosed F2 · derivative.exercise_price: Stock units are convertible into common stock on a 1-for-1 basis. F5 · shares: Represents 11,904.762 stock units accrued under the Plan in lieu of director cash compensation for the quarter ending June 30, 2019. F4 · derivative.exercise_date: Payment of amounts credited to the reporting person's stock unit account will be made upon a payment commencement event, as defined in the Plan, in accordance with the payment method elected by the reporting person, either in lump sum or in a number of annual installments, not to exceed 15 installments. F4 · derivative.expiration_date: Payment of amounts credited to the reporting person's stock unit account will be made upon a payment commencement event, as defined in the Plan, in accordance with the payment method elected by the reporting person, either in lump sum or in a number of annual installments, not to exceed 15 installments. Read SEC document |
| February 28, 2019 Filed Jun 3, 2019 21:21 UTC | Quorum Health Corp QHC · Entity 149783 | GrantStock Units · Derivative | 8,064.516 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-008607 · ownership.xml · derivative · entry 2 KAPLAN JON H. · CIK 0001751699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,064.516 Underlying: Common Stock · 8,064.516 shares Expires not disclosed F2 · derivative.exercise_price: Stock units are convertible into common stock on a 1-for-1 basis. F3 · shares: Represents 8,064.516 stock units accrued under the Quorum Health Corporation Amended and Restated Director's Fees Deferral Plan (the "Plan") in lieu of director cash compensation for the quarter ended March 31, 2019. F4 · derivative.exercise_date: Payment of amounts credited to the reporting person's stock unit account will be made upon a payment commencement event, as defined in the Plan, in accordance with the payment method elected by the reporting person, either in lump sum or in a number of annual installments, not to exceed 15 installments. F4 · derivative.expiration_date: Payment of amounts credited to the reporting person's stock unit account will be made upon a payment commencement event, as defined in the Plan, in accordance with the payment method elected by the reporting person, either in lump sum or in a number of annual installments, not to exceed 15 installments. Read SEC document |
| September 27, 2018 Filed Sep 28, 2018 17:46 UTC | Quorum Health Corp QHC · Entity 149783 | GrantCommon stock, par value $0.0001 per share | 20,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052617 · doc4.xml · nonDerivative · entry 1 KAPLAN JON H. · CIK 0001751699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,630 F1 · shares: On September 27, 2018, the reporting person received a grant of 20,630 shares of restricted common stock pursuant to the Quorum Health Corporation 2016 Stock Award Plan. 100% of the number of shares of restricted common stock issued shall vest on March 9, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.